EW stock is on investors' radars due to the promising structural heart opportunities following the divestment of the Critical Care arm.

IRVINE, CA / ACCESS Newswire / February 19, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, ...

For some patients with atrial fibrillation (Afib, AF) and valvular heart disease (VHD), direct oral anticoagulants (DOACs) ...

Despite guideline recommendations, the use of bioprosthetic heart valves has surpassed mechanical valves, but data from a ...

Interim follow-up data indicate sustained improvements across all venous specific quality-of-life (QoL) indicators. PMA application for the VenoValve submitted in November 2024, with an FDA decision ...

meaning that the blood doesn’t flow quite as smoothly as it does with a natural valve. This creates another opportunity for blood clots to form. A bioprosthetic or "tissue" valve created from cow or ...

Despite launching almost six years ago, the Valve Index is still able to keep up with many of today’s PC VR headsets. Of course, there have been plenty of headsets since then, including cheaper ...

However, little is known, on the effect of such procedures on pre-existing tricuspid regurgitation (TR). We assessed the potential reduction in the severity of TR after atrial septal defect (ASD) ...

Valve thrombosis can occur in mechanical prosthetic valves and is increasingly recognised in transcatheter and surgically implanted bioprosthetic valves. The risk of thrombosis of mechanical valves is ...

Pros of Artificial Valve Replacement Mechanical heart valves are less likely to require additional surgery to replace in the future than biological prosthetic (bioprosthetic) valves. Very strong. A ...

Introduction Pregnancy in patients with mechanical heart valves (MHVs) is associated with high maternal complications and fetal complications.Anticoagulation treatments serve to decrease their venous ...

and under expansion of the valve can lead to more platelet aggregation and stasis from neo-sinus creation. There is no difference in SLT rates between TAVR and bioprosthetic surgical aortic valve ...